139 related articles for article (PubMed ID: 37068736)
1. Comparison of Real-Time PCR and Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
Miller JA; Huang C; Yamamoto F; Sahoo MK; Le QT; Pinsky BA
J Mol Diagn; 2023 Jul; 25(7):490-501. PubMed ID: 37068736
[TBL] [Abstract][Full Text] [Related]
2. Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
Taverna F; Alfieri S; Romanò R; Campanini G; Marceglia S; Giardina F; Mazzocchi A; Comoli P; Gloghini A; Quattrone P; Bergamini C; Apollonio G; Filippini DM; Orlandi E; Locati LD; Licitra L; Baldanti F; Bossi P
Oral Oncol; 2022 Dec; 135():106229. PubMed ID: 36347145
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.
Vo JH; Nei WL; Hu M; Phyo WM; Wang F; Fong KW; Tan T; Soong YL; Cheah SL; Sommat K; Low H; Ling B; Ng J; Tan WL; Chan KS; Oon L; Ying JY; Tan MH
Sci Rep; 2016 Dec; 6(1):13. PubMed ID: 28442757
[TBL] [Abstract][Full Text] [Related]
4. An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.
Le QT; Zhang Q; Cao H; Cheng AJ; Pinsky BA; Hong RL; Chang JT; Wang CW; Tsao KC; Lo YD; Lee N; Ang KK; Chan AT; Chan KC
Clin Cancer Res; 2013 Apr; 19(8):2208-15. PubMed ID: 23459720
[TBL] [Abstract][Full Text] [Related]
5. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma.
Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL
Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906
[TBL] [Abstract][Full Text] [Related]
6. The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification.
Sanosyan A; Fayd'herbe de Maudave A; Bollore K; Zimmermann V; Foulongne V; Van de Perre P; Tuaillon E
PLoS One; 2017; 12(8):e0183856. PubMed ID: 28850597
[TBL] [Abstract][Full Text] [Related]
7. CRISPR Cas12a-mediated amplification-free digital DNA assay improves the diagnosis and surveillance of Nasopharyngeal carcinoma.
Jiang C; Zheng X; Lin L; Li X; Li X; Liao Y; Jia W; Shu B
Biosens Bioelectron; 2023 Oct; 237():115546. PubMed ID: 37523811
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
10. Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
Nicholls JM; Lee VH; Chan SK; Tsang KC; Choi CW; Kwong DL; Lam KO; Chan SY; Tong CC; So TH; Leung TW; Luk MY; Khong PL; Lee AW
Br J Cancer; 2019 Oct; 121(8):690-698. PubMed ID: 31527689
[TBL] [Abstract][Full Text] [Related]
11. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
Chen WJ; Xu WN; Wang HY; Chen XX; Li XQ; Xie SH; Lin DF; Cao SM
BMC Cancer; 2021 Jun; 21(1):651. PubMed ID: 34074258
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis.
Anh VNQ; Van Ba N; Anh DT; Ung ND; Hiep NH; Ly VT; Hang DTT; Sy BT; Chinh HD; Ky LM; Phong VT; Luu NK; Trung NT; Son HA; Van Luong H; Thuan ND; Tung NT; Tho HH
Cancer Control; 2020; 27(3):1073274820944286. PubMed ID: 32726136
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.
Simon J; Brenner N; Reich S; Langseth H; Hansen BT; Ursin G; Ferreiro-Iglesias A; Brennan P; Kreimer AR; Johansson M; Pring M; Nygard M; Waterboer T
Cancer Epidemiol; 2022 Apr; 77():102117. PubMed ID: 35121404
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
Zheng XH; Li XZ; Zhou T; Jiang CT; Tang CL; Deng CM; Liao Y; He YQ; Wang TM; Jia WH
Int J Cancer; 2023 Jun; 152(12):2629-2638. PubMed ID: 36878711
[TBL] [Abstract][Full Text] [Related]
15. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
[TBL] [Abstract][Full Text] [Related]
16. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
17. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
18. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
Sengar M; Chorghe S; Jadhav K; Singh S; Laskar SG; Pai P; Aggarwal JP; D'Cruz A; Chaturvedi P; Deshpande M; Chaukar D; Budrukkar A; Gupta T; Murthy V; Kane S; Thakur M; Rangarajan V; Kannan S; Shet T; Kode J
Head Neck; 2016 Apr; 38 Suppl 1():E1666-73. PubMed ID: 26667883
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus.
Vasudevan HN; Yom SS
Hematol Oncol Clin North Am; 2021 Oct; 35(5):963-971. PubMed ID: 34187713
[TBL] [Abstract][Full Text] [Related]
20. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
